Aegis Therapeutics, LLC
Records under this name other than the patents Aegis Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Back to Aegis Therapeutics, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,329,220 | Controlled Release Formulations Formerly held In force · High confidence | In force | High confidence | |
| US 8,530,463 | Multimodal Particulate Formulations Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,458,091 | Compositions and Methods for the Treatment of Opioid Overdose Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,998,927 | Stabilizing Alkylglycoside Compositions and Methods Thereof Term ended Term ended Nov 15, 2026 · High confidence | Term ended | Term ended Nov 15, 2026 | High confidence |
| US 8,846,044 | Stabilizing Alkylglycoside Compositions and Methods Thereof Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 8,772,231 | Stabilizing Alkylglycoside Compositions and Methods Thereof Term ended Term ended Aug 19, 2026 · High confidence | Term ended | Term ended Aug 19, 2026 | High confidence |
| US 7,425,542 | Stabilizing Alkylglycoside Compositions and Methods Thereof Term ended Term ended Jun 23, 2026 · High confidence | Term ended | Term ended Jun 23, 2026 | High confidence |
| US 9,446,134 | Stabilizing Alkylglycoside Compositions and Methods Thereof Term ended Term ended Jun 23, 2026 · High confidence | Term ended | Term ended Jun 23, 2026 | High confidence |
| US 10,046,025 | Stabilizing Alkylglycoside Compositions and Methods Thereof Term ended Term ended Jun 23, 2026 · High confidence | Term ended | Term ended Jun 23, 2026 | High confidence |
| US 8,883,728 | Intranasal Administration of Active Agents to the Central Nervous System Term ended Term ended Jun 17, 2026 · Medium confidence | Term ended | Term ended Jun 17, 2026 | Medium confidence |